Search
forResearch 10 of 47
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Efficacy and safety of topical calcipotriol in management of alopecia areata: A pilot study
- Baricitinib for the Treatment of Alopecia Areata
- Efficacy, safety, and Pharmacoeconomics of Three Common Strategies for Pediatric Alopecia Areata Patients: A Retrospective Cohort Study
- Comparative Efficacy of JAK Inhibitors in Acute vs Nonacute Alopecia Areata: A Retrospective Cohort Study
- Tofacitinib for the treatment of alopecia areata and variants in adolescents
- Dupilumab induces hair regrowth in pediatric alopecia areata: a real-world, single-center observational study
- Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study
- Exploring the efficacy of baricitinib in treating alopecia areata after failed Janus kinase inhibitor therapy
- Alopecia areata. Diagnostic and therapeutic recommendations of the Polish Society of Dermatology. Part 2: Treatment
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →